Middle East And Africa Cytokine Based Therapies And Inhibitors Market By Type (Interleukins, Tumor Necrosis Factor, Epidermal Growth Factor, Interferon And Chemokine), By Therapeutic Application (Inflammatory And Immune Disorders, Cancer And Malignancies, Infectious Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Middle East And Africa Cytokine Based Therapies And Inhibitors Market By Type (Interleukins, Tumor Necrosis Factor, Epidermal Growth Factor, Interferon And Chemokine), By Therapeutic Application (Inflammatory And Immune Disorders, Cancer And Malignancies, Infectious Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 8263 | Pages: 145 | July 2018 | Region: Middle East and Africa


Cytokine Based Therapies and Inhibitors is a branch of science combining biology and engineering. It brings together several disciplines from both these fields such as genetic engineering, biotechnology, molecular engineering, computer engineering and evolutionary biology. In Cytokine Based Therapies and Inhibitors, these disciplines are applied to build artificial biological systems to be used in engineering, research and medical applications.

Middle East And Africa Cytokine Based Therapies And Inhibitors Market  was worth USD xx billion in 2018 and is projected to grow at a CAGR of xx%, to reach USD xx billion by 2023.

To achieve the intended biological system through DNA modification or sequencing, technology plays a major role. Computer aided designs are needed to model the designs accurately and technologies which can read and write DNA are highly useful. By combining advances in biology with the modern technologies, organisms can be designed to produce several chemicals or enzymes or biofuels.

Increasing expenditure on research and development of biotechnology and pharmaceutical companies, increasing demand for genetically modified crops and major technological advancements in DNA studies are the major factors driving the market growth. Increasing demand for alternate fuels such as biofuels and growing popularity for protein therapeutics are also expected to propel the market growth. However, ethical concerns regarding the biosafety and biosecurity and stringent regulations are hindering the growth of the market.

The Cytokine Based Therapies and Inhibitors market is categorized by type, therapeutic application and region. Based on type of cytokines, the market is categorized into Interleukins, Tumor necrosis factor, epidermal growth factor, Interferon and Chemokine. Xeno nucleic acid is the largest market segment due to the high demand for synthetic alternatives to nucleic acids DNA and RNA. On the basis of therapeutic application, the market is categorized into Inflammatory and immune disorders, Cancer & malignancies, Infectious diseases and others. Enabled technologies are expected to be the largest market segment and enabling technologies are the fastest growing market segment due to several ongoing researches which might result in innovative technologies or ideas for application of Cytokine Based Therapies and Inhibitors. Enabling technologies are again categorized into Gene Synthesis, Cloning and Sequencing, Genome Engineering, Bioinformatics, Nanotechnology, Site-Directed Mutagenesis, Microfluidics and Measurement and Modeling. Gene synthesis is the major market segment in enabling technologies due to the increasing demand for protein synthesis through synthetic means. Enabled technologies are further categorized into Next-Generation Sequencing and Pathway Engineering.

On the basis of region, the Middle East and Africa Cytokine Based Therapies and Inhibitors market is categorized into Middle East and Africa.The market in this region is expected to have a low growth rate during the forecast period.

Some of the major players in Cytokine Based Therapies and Inhibitors market are GlaxoSmithKline LLC, AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Immunochemistry Technologies LLC, Roche Diagnostics, Novartis, Merck Sharp & Dohme Corp., Johnson & Johnson and Amgen Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Interleukins            

                                5.1.3 Tumor necrosis factor        

                                5.1.4 Epidermal growth factor   

                                5.1.5 Interferon               

                                5.1.6 Chemokine             

                                5.1.7  Y-o-Y Growth Analysis, By Type    

                                5.1.8  Market Attractiveness Analysis, By Type  

                                5.1.9  Market Share Analysis, By Type    

                5.2 Therapeutic Application                        

                                5.2.1 Introduction           

                                5.2.2 Inflammatory and immune disorders          

                                5.2.3 Cancer and malignancies   

                                5.2.4 Infectious diseases              

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Therapeutic Application               

                                5.2.7 Market Attractiveness Analysis, By Therapeutic Application             

                                5.2.8 Market Share Analysis, By Therapeutic Application               

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Therapeutic Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Therapeutic Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Therapeutic Application

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 GlaxoSmithKline LLC                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AbbVie Inc.                 

                8.3 Eli Lilly and Company                              

                8.4 Genentech, Inc                         

                8.5 Immunochemistry Technologies LLC                               

                8.6 Roche Diagnostics                    

                8.7 Novartis                       

                8.8 Merck Sharp & Dohme Corp                               

                8.9 Johnson & Johnson                 

                8.10 Amgen Inc                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  •  
  • Segment-level analysis in terms of Product and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East and Africa Cytokine Based Therapies and Inhibitors Market Market By Type, From 2018-2023 ( USD Billion )
  2. Middle East and Africa Interleukins Market By Region, From 2018-2023 ( USD Billion )
  3. Middle East and Africa Tumor necrosis factor Market By Region, From 2018-2023 ( USD Billion )
  4. Middle East and Africa Epidermal growth factor Market By Region, From 2018-2023 ( USD Billion )
  5. Middle East and Africa Interferon Market By Region, From 2018-2023 ( USD Billion )
  6. Middle East and Africa Chemokine Market By Region, From 2018-2023 ( USD Billion )
  7. Middle East and Africa Cytokine Based Therapies and Inhibitors Market Market By Therapeutic Application, From 2018-2023 ( USD Billion )
  8. Middle East and Africa Inflammatory and immune disorders Market By Region, From 2018-2023 ( USD Billion )
  9. Middle East and Africa Cancer and malignancies Market By Region, From 2018-2023 ( USD Billion )
  10. Middle East and Africa Infectious diseases  Market By Region, From 2018-2023 ( USD Billion )
  11. Middle East and Africa Others Market By Region, From 2018-2023 ( USD Billion )
  12. Middle East Cytokine Based Therapies and Inhibitors Market Market By Type, From 2018-2023 ( USD Billion )
  13. Middle East Cytokine Based Therapies and Inhibitors Market Market By Therapeutic Application, From 2018-2023 ( USD Billion )
  14. Africa Cytokine Based Therapies and Inhibitors Market Market By Type, From 2018-2023 ( USD Billion )
  15. Africa Cytokine Based Therapies and Inhibitors Market Market By Therapeutic Application, From 2018-2023 ( USD Billion )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.